ENCAB000AJH

Antibody against Homo sapiens NR2F2

Homo sapiens
K562, HepG2, liver, MCF-7
characterized to standards with exemption
Status
released
Source (vendor)
Santa Cruz Biotech
Product ID
sc-271940
Lot ID
I1410
Characterized targets
NR2F2 (Homo sapiens)
Host
mouse
Clonality
monoclonal
Purification
affinity
Isotype
IgG
Antigen description
Epitope mapping between amino acids 13-44 at the N-terminus of NR2F2 of human origin.

Characterizations

NR2F2 (Homo sapiens)
K562HepG2
Method: immunoblot
Attachment from submitter
exempt from standards
Caption
Western blot protocol: Whole cell lysate was immunoprecipitated using primary antibody, and the IP fraction was loaded on a 12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. After separation, the samples were transferred to a nitrocellulose membrane with an Invitrogen iBlot system. Blotting with primary (same as that used for IP) and secondary HRP-conjugated antibodies was performed on an Invitrogen BenchPro 4100 system. Visualization was achieved using SuperSignal West Femto solution (Thermo Scientific). Results: Band of expected size visualized at ~47 kDa. Upper bands also visualized. Both bands tested by IP-mass spec in Validation 2. Figure legend: IP-western with sc-271940 in whole cell lysate (WCL) of K562 and HepG2; PM=protein marker. NR2F2 bands are indicated (as determined by mass spec in Validation 2). Expected size ~45 kDa.
Submitter comment
--
Reviewer comment
Band is not 50% of overall signal
Submitted by
Richard Myers
Lab
Richard Myers, HAIB
NR2F2 (Homo sapiens)
liver
Method: immunoblot
Attachment from submitter
exempt from standards
Caption
The ENCODE Binding Working Group finds for some valuable tissues that recreating a primary on well characterized antibodies is not cost effective. Therefore, they allow exemption from standards for these tissues.
Submitter comment
The lab is asking for an exemption for liver cells due to the lack of resource to make a primary characterization for them
Reviewer comment
Exempted by the Feb 29, 2016 antibody review panel
Submitted by
Richard Myers
Lab
Richard Myers, HAIB
Download
NR2F2 (Homo sapiens)
K562HepG2MCF-7
Method: immunoblot
Attachment from submitter
exempt from standards
Caption
Whole cell lysates of K562, MCF7, and HepG2 were immunoprecipitated using the primary antibody (Santa Cruz Biotechnology; sc-271940). The IP fraction was separated on a 12% acrylamide gel with the Bio-Rad PROTEAN II xi system. After separation, the samples were transferred to a nitrocellulose membrane with an Invitrogen iBlot system. The membrane was probed with the primary antibody (same as that used for IP) and a secondary HRP-conjugated antibody. The resulting bands were visualized with SuperSignal West Femto Solution (Thermo Scientific). Protein Marker (PM) is labeled in kDa. The approximate size of NR2F2 is ~45 kDa.
Submitter comment
--
Reviewer comment
Band is not clearly absent from the IgG control lane and is not strong in the signal lane. Rescued by mass spec
Submitted by
Mark Mackiewicz
Lab
Richard Myers, HAIB
NR2F2 (Homo sapiens)
Method: immunoprecipitation followed by mass spectrometry
Attachment from submitter
compliant
Caption
IP followed by mass spectrometry: Briefly, K562 whole cell lysates were immunoprecipitated using primary antibody, and the IP fraction was loaded on a 12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. The gel was stained with Coomassie Blue in order to visualize marker bands. Gel fragments corresponding to the bands indicated above in the western blot image were excised and sent to the University of Alabama at Birmingham Cancer Center Mass Spectrometry/Proteomics Shared Facility. There the samples were run on an LTQ XL Linear Ion Trap Mass Spectrometer by LC-ESI-MS/MS. Peptides were identified using SEQUEST tandem mass spectra analysis, with probability based matching at p < 0.05. As per ENCODE data standards, all SEQUEST results are attached (ENCODE_HAIB_NR2F2_sc271940_12072011_MassSpec.pdf), including common contaminants. Target protein is listed as entry number 15a with 0.9999% probability in the ~45 kDa band and is not present in the upper (~80 and 90 kDa) bands.
Reviewer comment
ENCODE2 characterization passes ENCODE3 standards
Submitted by
Richard Myers
Lab
Richard Myers, HAIB